Trial intelligence / Profile preview

Intracoronary rhBNP adjunct to primary PCI in STEMI

ChiCTR-TRC-08000072Phase 4Completed

Sponsor
Renji Hospital
Start
Apr 2008
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in myocardial infarction (MI) comparing Saline Group, Verapamil Group and BNP Group (3 arms). Primary endpoints: Wall motion score index in echocardiography and TIMI myocardial perfusion grade. Started Apr 2008; status: completed.

02

Drugs

nesiritideverapamilsaline
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on ChiCTR-TRC-08000072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-08000072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call